0001213900-22-061373.txt : 20221003
0001213900-22-061373.hdr.sgml : 20221003
20221003185231
ACCESSION NUMBER: 0001213900-22-061373
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221001
FILED AS OF DATE: 20221003
DATE AS OF CHANGE: 20221003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McLaughlin Gerald W.
CENTRAL INDEX KEY: 0001495412
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41160
FILM NUMBER: 221289074
MAIL ADDRESS:
STREET 1: 227 WASHINGTON STREET
STREET 2: SUITE 200
CITY: CONSHOHOCKEN
STATE: PA
ZIP: 19428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allarity Therapeutics, Inc.
CENTRAL INDEX KEY: 0001860657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 BROADWAY
STREET 2: SUITE 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 401-426-4664
MAIL ADDRESS:
STREET 1: 210 BROADWAY
STREET 2: SUITE 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
3
1
ownership.xml
X0206
3
2022-10-01
0
0001860657
Allarity Therapeutics, Inc.
ALLR
0001495412
McLaughlin Gerald W.
C/O ALLARITY THERAPEUTICS, INC.
210 BROADWAY, SUITE 201
CAMBRIDGE,
MA
02139
1
0
0
0
Stock Options
1.10
2027-10-01
Common Stock
23000
D
Pursuant to the Issuer's 2021 Equity Incentive Plan (the "Plan"), the Reporting Person was granted 23,000 non-qualified stock options (the "Options") at the exercise price of $1.10. The Options were granted on October 1, 2022 (the "Grant Date"), and vest 1/36 per month over a three year period commencing as of the Grant Date. The Options were granted to the Reporting Person, who is a non-executive director of the Issuer, in a transaction exempt under Rule 16b-3 to the Reporting Person.
/s/ Gerald W. McLaughlin
2022-10-01